Walleye Capital’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1K | Sell |
809
-8,252
| -91% | -$297K | ﹤0.01% | 1705 |
|
|
2025
Q1 | $357K | Sell |
9,061
-14,808
| -62% | -$584K | ﹤0.01% | 1199 |
|
|
2024
Q4 | $718K | Buy |
23,869
+18,623
| +355% | +$561K | ﹤0.01% | 1042 |
|
|
2024
Q3 | $123K | Buy |
+5,246
| New | +$123K | ﹤0.01% | 1848 |
|
|
2024
Q2 | – | Sell |
-11,017
| Closed | -$168K | – | 2965 |
|
|
2024
Q1 | $168K | Buy |
11,017
+1,253
| +13% | +$19.1K | ﹤0.01% | 1869 |
|
|
2023
Q4 | $167K | Sell |
9,764
-79,409
| -89% | -$1.36M | ﹤0.01% | 1518 |
|
|
2023
Q3 | $745K | Buy |
+89,173
| New | +$745K | ﹤0.01% | 995 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2817 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2702 |
|
|
2022
Q3 | – | Sell |
-198,233
| Closed | -$842K | – | 2739 |
|
|
2022
Q2 | $842K | Buy |
+198,233
| New | +$842K | 0.02% | 719 |
|
|
2020
Q2 | – | Sell |
-16,540
| Closed | -$162K | – | 780 |
|
|
2020
Q1 | $162K | Sell |
16,540
-13,860
| -46% | -$136K | 0.04% | 314 |
|
|
2019
Q4 | $338K | Buy |
+30,400
| New | +$338K | 0.02% | 265 |
|